Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer
Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer
Co-Diagnostics, Inc. 任命理查德·阿伯特为总裁，同时该公司任命戴维·尼尔森为其首席运营官
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that last month the Board of Directors appointed Richard Abbott as President of Co-Diagnostics, Inc., concurrent with the Company naming David Nielsen to be its Chief Operations Officer (COO), Christopher Thurston as its Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO).
拥有专利分子诊断测试开发平台的分子诊断公司Co-Diagnostics, Inc.（纳斯达克股票代码：CODX）（“Co-Dx” 或 “公司”）今天宣布，上个月董事会任命理查德·阿伯特为Co-Diagnostics, Inc.总裁，同时任命戴维·尼尔森为首席运营官（COO），克里斯托弗·瑟斯顿为首席技术官（首席技术官），塞思·伊根担任首席商业化官（CCO）。
Prior to his new role at the Company, Richard Abbott (President) served as the President of Advanced Conceptions, Inc., a wholly-owned subsidiary of Co-Diagnostics...
在公司担任新职务之前，理查德·阿伯特（总裁）自202...
登录免费看全文
登录/注册